{
    "nctId": "NCT04515888",
    "briefTitle": "Evaluation of the Prevalence of Pelvic Static Disorders in Women With Localized Breast Cancer",
    "officialTitle": "Evaluation of the Prevalence of Pelvic Static Disorders in Women Treated for Localized Breast Cancer During Adjuvant Hormone Therapy.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 246,
    "primaryOutcomeMeasure": "Evaluate the prevalence of pelvic static disorders in patients treated for localized breast cancer and undergoing adjuvant hormone therapy (Hormontherapy +).",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women with Age \u2265 50 years\n* Menopaused\n* Patient followed for carcinoma in situ or infiltrating the breast with or without hormone therapy\n* Patient who was treated by surgery after June 2015, whether or not followed by radiotherapy or chemotherapy.\n* Patient who agreed, after receiving information, to participate to the study.\n\nExclusion Criteria:\n\n* Metastatic breast cancer\n* Patient with a history of pelvic static surgery\n* Patient with a history of pelvic irradiation\n* Patient unable or unwilling to complete the questionnaires\n* Patient with a history of urinary incontinence treatment\n* Patient not affiliated to the French social security system\n* Subject under tutelage, curatorship or safeguard of justice,\n* Patient in an emergency situation,\n* Patient whose regular monitoring is impossible for psychological, family, social or geographical reasons,\n* Pregnant and / or breastfeeding woman.",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}